EMN vs GNLX · P/E 21, rev $9.38B vs rev $8.0K
Eastman Chemical Company (EMN) versus Genelux Corporation Common Stock (GNLX) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. GNLX currently screens at market cap $130.6M.
Not investment advice. Open the EMN and GNLX stock pages for the full models.
Not investment advice.